GlucoTrack (NASDAQ:GCTK – Get Free Report) and NeurAxis (NASDAQ:NRXS – Get Free Report) are both small-cap healthcare companies, but which is the better business? Insider & Institutional Ownership10.9% of GlucoTrack shares are owned by institutional investors. Comparatively, 11.8% of NeurAxis shares are owned by institutional investors. 8.4% of GlucoTrack shares are owned by company insiders. Given NeurAxis’ stronger consensus rating and higher probable upside, analysts clearly believe NeurAxis is more favorable than GlucoTrack.